Quark Ventures: Quark Venture and GF Securities Invest Through the Global Health Sciences Fund in Biscayne Neurotherapeutics to Advance A Novel Anti-Epileptic Agent

VANCOUVER, BRITISH COLUMBIA and MIAMI, FLORIDA -- (Marketwired) -- 01/27/17 -- Today, Quark Venture Inc., and GF Securities announced a US$1.6 million investment in Biscayne Neurotherapeutics (Bis...